Renal cell carcinoma marker单克隆
抗体, 克隆号66.4.C2 | Renal cell carcinoma marker monoclonal antibody, clone 66.4.C2- 询价
- 艾美捷Abnova
- 美国
- MAB9505
- 2025年07月09日
- 小鼠
企业认证
相关产品推荐更多 >
![CEA 抗体 [SPM541]-CEA Antibody [SPM541]](https://img1.dxycdn.com/p/s14/2023/1218/191/8638588858174956371.jpg!wh200)
CEA 抗体 [SPM541]-CEA Antibody [SPM541]
￥22
mFluor™ Violet 510 Anti-human CD55 Antibody *HI55a*/mFluor™ Violet 510 Anti-human CD55 Antibody *HI55a*/mFluor™ Violet 510 Anti-human CD55 Antibody *HI55a*
询价
肿瘤坏死因子甲抗体/肿瘤坏死因子甲抗体/肿瘤坏死因子甲抗体
询价
Progesterone Receptor Membrane Component 2 (PGRMC2) Antibody/Progesterone Receptor Membrane Component 2 (PGRMC2) Antibody/Progesterone Receptor Membrane Component 2 (PGRMC2) Antibody
询价
抗小鼠TCR V gamma 2体内抗体-低内毒素 (UC3-10A6)/Anti-Mouse TCR V gamma 2 In Vivo Antibody - Low Endotoxin (UC3-10A6)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性：
单克隆抗体
- 宿主：
小鼠
- 抗体英文名：
Renal cell carcinoma marker monoclonal antibody, clone 66.4.C2
- 抗体名：
Renal cell carcinoma marker单克隆抗体, 克隆号66.4.C2
- 规格：
1 mL
【产品形式】：艾美捷为您提供的Renal cell carcinoma marker单克隆抗体, 克隆号66.4.C2为单克隆抗体。
【背景资料】：提供的Renalcellcarcinomamarker单克隆抗体,克隆号66.4.C2是从小鼠体内制备的单克隆抗体，其克隆号为66.4.C2。
作为全世界最大的单克隆抗体和蛋白生产商，Abnova的金牌品质使其成为全球最主要抗体品牌的供应商，您可以在各个主要抗体品牌，如Abcam、 Sigma、Novus、AbD等知名品牌的目录上都能发现Abnova的抗体。作为Abnova最关键的合作伙伴和中国区域总代理，艾美捷科技有限公司凭借丰富的专业经 验，将一如既往的为中国区域客户提供Abnova优质的产品和技术服务，包括各种抗体、重组蛋白、抗体对、ELISA试剂盒、原位杂交荧光探针、蛋白定量 以及可用于蛋白翻译研究、诊断和制药公司应用的基础型体外诊断设备等。更多特色试剂盒、特色抗体以及特色试剂等产品评论，请点击查看中国生命科学试剂产品评论网站。
点击Renal cell carcinoma marker单克隆抗体, 克隆号66.4.C2查看更详细产品说明，更多应用、种属反应性、储存、价格、货期等信息请致电400-6800-868垂询Abnova中国区域授权总代理艾美捷科技有限公司。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Transforming Growth Factor-1 as a Novel Marker of Response to Therapy for Renal Cell Carcinoma
Renal cell carcinoma is expected to account for 30,000 new cancer cases and 11,900 cancer deaths in the United States in 1999 (1 ). At the time of initial presentation, up to one-third of patients with renal cell carcinoma (RCC) have metastatic
Orthotopic Model of Renal Cell Carcinoma
A human renal cancer was first established in continuous culture in 1962. Currently, there are well over 100 different characterized renal cancer cell lines derived from both primary and metastatic renal cell carcinomas (RCCs) (1 –
Detection of Apoptosis in Renal Cell Carcinoma
correlated with tumor grade, stage, and size in renal cell carcinoma (RCC) (1 ). Apoptosis is closely related to proliferative activity, tumor differentiation, and depth of invasion in transitional-cell carcinoma of the renal pelvis and ureter
技术资料暂无技术资料 索取技术资料
